SCHEMBL5725280

SCHEMBL5725280

COc1ccc2[nH]c(SCc3ncc(C)c(OC)c3C)nc2c1S(=O)(=O)c1c(C)cc([O])cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 2/20 0.55
CYP2C9 P11712 2/20 0.41
SHMT2 P34897 1/20 0.39
WDR5 P61964 3/20 0.38
KMT2A Q03164 3/20 0.38
DDAH1 O94760 2/20 0.38
ENGASE Q8NFI3 2/20 0.38
ATP1A1 P05023 2/20 0.38
ATP1B1 P05026 2/20 0.38
ATP1A3 P13637 2/20 0.38
ATP1B2 P14415 2/20 0.38
ATP4A P20648 2/20 0.38
ATP1A2 P50993 2/20 0.38
ATP4B P51164 2/20 0.38
ATP1B3 P54709 2/20 0.38
FXYD2 P54710 2/20 0.38
ATP1A4 Q13733 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5363676 0.88 BRS3 (0.52) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL6505209 0.86 BRS3 (0.50) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL5358476 0.82 BRS3 (0.49) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL5730609 0.81 CYP2C9 (0.44) BRS3CYP2C9WDR5KMT2ADDAH1
SCHEMBL5764036 0.81 CYP2C9 (0.40) BRS3CYP2C9WDR5KMT2ADDAH1
SCHEMBL5367604 0.81 BRS3 (0.51) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL5367213 0.80 BRS3 (0.44) BRS3CYP2C9WDR5KMT2ADDAH1
SCHEMBL5446484 0.79 BRS3 (0.49) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL5369638 0.77 BRS3 (0.43) BRS3CYP2C9SHMT2WDR5KMT2A
SCHEMBL5364325 0.75 BRS3 (0.42) BRS3CYP2C9SHMT2KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644352-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS Allergan, Inc. (US) 2006-04-12 EP disclosed
WO-2005016917-A1 PROCESS FOR PREPARING ISOMERICALLY PURE PRODRUGS OF PROTON PUMP INHIBITORS ALLERGAN, INC. (US) 2005-02-24 WO disclosed